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Abstract
Mucins locate to the apical surfaces of all wet-surfaced epithelia including ocular surface. The functions of the
mucins include anti-adhesive, lubrication, water retention, allergens and pathogen barrier function. Ocular surface
pathologies, i.e. dry eye syndrome or allergic conjunctivitis, are reportedly associated with alteration of expression
pattern of mucin components. Recent investigations indicated anti-bacterial adhesion or anti-inflammatory effects
of members of mucins in non-ocular tissues, i.e., gastrointestinal tracts or airway tissues, by using genetically
modified mouse lines that lacks an expression of a mucin member. However, examination of ocular phenotypes of
each of mucin gene-ablated mouse lines has not yet fully performed. Muc16-dficient mouse is associated with
spontaneous subclinical inflammation in conjunctiva. The article reviews the roles of mucin members in modulation
of local inflammation in mucous membrane tissues and phenotype of mouse lines with the loss of a mucin gene.
Analysis of ocular surface of mucin-gene related mutant mouse lines are to be further performed.
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Introduction
Mucins are a class of high-molecular weight hydrophilic
glycoproteins that contain multiple tandem repeats of
amino acids that are rich in serine and threonine in the
central domain of the core peptide [1] and locate to the
apical surfaces of all wet-surfaced epithelia [2]. The
number of amino acids per tandem repeat differs among
each mucin molecule [3, 4]. Epithelial mucins are cate-
gorized as secreted and membrane-associated mucins
(MAMs). Secreted mucins have no transmembrane-
spanning domains and are produced by goblet cells [5].
The secreted mucins have the capability to capture aller-
gens, cell debris and pathogens to facilitate their clear-
ance from mucosal surfaces [6]. MAMs have a short
cytoplasmic tail, a single transmembrane domain, an
autoproteolytic domain, and a large, heavily glycosylated
extracellular domain that contributes to the formation of
the glycocalyx of apical cells in wet-surfaced epithelia
[2]. Although the functions of the MAMs include anti-
adhesive, lubrication, water retention, pathogen barrier
function [2, 7], Recent investigations indicate anti-
inflammatory effects of mucins in gastrointestinal tract
or eye conjunctiva [8, 9]. In the current article the im-
portance of mucins in ophthalmological clinical setting
was described. Although cell culture studies on the roles
of mucins have intensively conducted, they failed to
figure out the roles of each mucin members in vivo.
Such disadvantage of in vitro studies has well overcome
by the availability of genetically mucin-gene-modified
mouse lines. The roles of mucins in maintenance of ocu-
lar surface homeostasis as revealed by using mouse lines
with ablation of each mucin gene were reviewed with a
special interest in the regulation of tissue inflammation
in the ocular surface inflammation.
Classification of mucins and their distribution in the
ocular surface
Mucins identified in humans are designated as MUC,
mouse homologues are identified by Muc and rat homo-
logues are identified by rMuc. Epithelial mucins are
categorized as secreted mucins and MAMs (Table 1).
Secreted mucins including MUC2 and MUC5AC
(Muc5AC in mice) have no transmembrane-spanning
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domains and are produced by goblet cells [5].
MUC5AC tend to form polymers in the goblet cells,
where they are stored, but are secreted as monomers
in the tear film (Fig. 1) [10]. MUC5AC spreads in tear
film and decreases in density from the epithelial sur-
face toward the lipid layer [11]. MUC5AC reportedly
has the capability to trap allergens, debris and patho-
gens in order to facilitate their clearance from mucosal
surfaces [6].
MAMs, i.e., MUC1, MUC4 and MUC16 (Muc1, Muc4
and Muc16 in mice), have a short cytoplasmic tail, a sin-
gle transmembrane domain, an autoproteolytic domain,
and a large, heavily glycosylated extracellular domain
that contributes to the formation of the glycocalyx of ap-
ical cells in wet-surfaced epithelia [2]. The ocular surface
epithelia express three MAMs (MUC1, MUC4 and
MUC16), that are concentrated on the tips of the apical
cells’ microplicae, forming a dense glycocalyx at the
epithelial-tear film interface [2], but MAM’s extracellular
domains can also be released from the epithelial cell sur-
face as soluble forms and are found in the tear film
(Shedding) (Fig. 1) [10, 12]. MUC1 is expressed in both
corneal and conjunctival epithelia [13, 14]. Interestingly
the cytoplasmic domain of MUC1 play a role similar
to transcription factor when being freed from cytoplas-
mic membrane; cytoplasmic tail of MUC1 interacts with
β-catenin, is transported to the nucleus and modulates
transcription of genes involved in cell proliferation and
differentiation [15, 16]. MUC4 is most prevalent in con-
junctival epithelia with an apparent diminution toward
the central corneal epithelium in humans [14, 17]. In
contrast, there is a high level of expression of Muc4 and
rMuc4in the conjunctiva and cornea of mice and rats
[18, 19]. MUC16 is initially known as the CA125 tumor
antigen, that is commonly used as a marker of the presence
and progression of certain malignant tumors [20–22].
MUC16/CA125 was then found to be widely expressed in
normal tissues as a member of MAMs. In the ocular tissue
MUC16 is expressed in epithelia of both cornea and con-
junctiva in human [14, 23], but only in conjunctiva in
mice [9, 24]. MUC16 is localized in the microplicae on the
surface of the corneal and conjunctival epithelia, and bind
to the actin cytoskeleton with its cytoplasmic tails [25],
suggesting the roles of Muc16 in the maintenance of the
microplicae architecture.
Table 1 Characteristic of ocular surface mucins
Type Chromosome position
MUC1 membrane asociated 1q21-q23
MUC4 membrane asociated 3q29
MUC5AC secretory 11p15
MUC16 membrane asociated 19p13 · 2
Fig. 1 Ocular surface mucins. The ocular surface epithelia express three MAMs, that are concentrated on the tips of the apical cells’ microplicae.
Secreted mucins are produced by Goblet cells and secreted in the tear film. The loss of Muc16 activates Stat3 signaling in fibroblasts in the
subconjunctival connective tissue and upregulates expression of cytokine. Reproduced from [67]
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The roles of mucins in ocular surface
The secreted mucins have the capability to capture aller-
gens, cell debris and pathogens to facilitate their clear-
ance from mucosal surfaces [6]. The functions of the
MAMs include anti-adhesive, lubrication, water reten-
tion, pathogen barrier function [2, 7], anti-inflammatory
effects [8, 9].
Dry eye syndrome and mucins
Dry eye is a multifactorial disorder in the ocular surface,
and causes ocular dryness, discomfort, visual disturbance
and others. The disease mechanism include long-
standing local inflammation in the conjuctiva and cor-
nea, dysfunction of lacrimal gland with disturbance of
tear secretion, meibomian gland dysfunction, reduction
of mucin expression, and others, all of which potentially
cause damage of the ocular surface epithelia [26, 27]. Al-
though dryness of the ocular surface is a fundamental
situation, local inflammation in the epithelium plays crit-
ical roles in the pathogenesis and symptom in patients
with dry eye syndrome [26, 27]. Exaggerated evaporation
of tear water increases the tear film osmolarity in dry
eye. Besides the cellular response to the environmental
hyperosmolarity through cation channel receptors, e. g.
TRPV1, MAMs also could have the function of sensing
the environmental hyperosmolarity through their extra-
cellular domain and might transmit signal via their intra-
cellular domain [28]. Expression of interleukin 6 (IL-6)
and TNFα is upregulated by local tissue dryness in con-
junctiva of dry eye patients and experimental dry eye
model [29]. The desiccation of human corneal epithelial
cell line cells increased IL-6 and TNFα level measured
by ELISA [29]. In the dry eye model of rats, the IL-6 and
TNFα mRNA level in the cornea measured by real-time
RT-PCR increased [29]. It is quite interesting topic if
mucin deficiency leads to inflammation in the ocular
surface or vice versa, if upregulation of inflammatory cy-
tokines/growth factors suppresses mucin expression in
corneal and conjunctival epithelium. Expressions of
MUC1, MUC2, MUC4, and MUC5AC are significantly
lower in conjunctival epithelium gathered by impression
cytology in the patients with dry eye syndrome com-
pared with that in normal subject [30]. Especially, reduc-
tion of MUC1 expression in dry eye local tissue is
reportedly most prominent and could be a marker for
diagnosis or evaluation of the disease severity [30]. This
point will be discussed in detail below. However, another
study reports that expression of MUC1 protein and
mRNA measured by western blotting and real-time PCR
increases in the conjunctival epithelial cells gathered by
impression cytology in the patients with Sjogren’s syn-
drome [31], suggesting further study is needed to un-
cover the mechanism of regulation of secretion of mucin
components in dry eye-related ocular surface.
Topical benzalkonium chloride (BAC), a preservative
in ophthalmic solution, induces reduction of tear film
breakup time, increasing of corneal epithelial permeabil-
ity, inflammatory infiltration, apoptosis, and squamous
metaplasia. This condition could be investigated as an
experimental model of dry eye in animals [32–34]. Top-
ical BAC reduces MUC5AC-positive goblet cells in ani-
mal conjunctival fornix with impairment of arrangement
of the microvillis of the corneal epithelium [32]. Immu-
nolabeling revealed fewer MUC5AC-positive goblet cells
in the BAC-treated conjunctival fornix in mice [32]. Cell
culture study also showed the effects of an exposure to
BAC in cultured corneal epithelial cells [35, 36]. mRNA
expression of MUC1 and MUC16 measured by real-time
RT-PCR was not changed, but protein level of a MUC1
and MUC16 examined by western blot analysis was
reduced in cultured human corneal epithelial cells fol-
lowing exposure to eyedrops containing BAC solutions
[35]. Currently most of the eyedrops contain preserva-
tives, e. g. BAC, and thus, as stated above, it is required
to consider effects of BAC on ocular surface epithelium
and mucin condition.
Anti-inflammatory roles of mucins
Mucins exhibit anti-inflammatory effects. Ocular surface
epithelia are continuously exposed to allergens, debris,
pathogens, desiccation, injury, and rubbing. Because mu-
cins are considered to modulate local tissue inflamma-
tion as described above, it is hypothesized that the loss
of a mucin member might induce expression of inflam-
matory cytokines in a mouse conjunctiva. Ocular surface
mucins contribute differently to the protection of the
ocular surface against allergens, pathogens, extracellular
molecules, abrasive stress, and drying. Topical eyedrop
of rebamipide, a drug that is capable of stimulating of
mucin secretion in gastrointestinal tract or conjunctiva,
is approved in Japanese government for use in the treat-
ment of dry eye diseases (Table 2). It was reported that
rebamipide exerts an anti-inflammatory effects on the
ocular surface upon topical exposure to polyI:C in pri-
mary human conjunctival epithelial cells as revealed by
quantitative RT-PCR analysis of mRNA expression of
CXCL10, CXCL11, RANTES, MCP-1, and IL-6 [37].
Allergic conjunctivitis and mucins
Impression cytology specimens from the patients with
atopic keratoconjunctivitis picks up immunohistochemcal
labeling for MUC5AC and MUC16 [38]. Expression of
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goblet cell-specific mucin, MUC5AC mRNA, is reduced
and MUC16 mRNA expression is upregulated in brush
cytology specimens from the patients with atopic kerato-
conjunctivitis [38]. On the other hand, patients with
vernal keratoconjunctivitis have increased numbers of
conjunctival goblet cells from impression cytology speci-
men [39]. Brush cytology specimens from eyes with atopic
keratoconjunctivitis show higher MUC1, 2, and 4 and
lower MUC5AC mRNA expression compared to the spec-
imens from eyes with vernal keratoconjunctivitis [40], al-
though the clinical manifestation of these two entities is
quite similar. The reason for this discrepancy is to be un-
covered. In mouse model of allergic conjunctivitis, repeti-
tive application of allergens (cat danger or peptide P3-1)
reduces the number of secretary granule-filled goblet cells
and a decrease in Muc5AC and Muc4 mRNA measured
by real-time RT-PCR [41]. After a period of 24 to 48 h,
the number of goblet cells and mucin mRNA levels return
to normal range [41]. Cytokines/growth factors expressed
in the inflammatory/immune cells infiltrated to subcon-
junctival tissue are considered to be attributable to the al-
teration of mucins expression in the ocular surface.
Modulation of mucin expression might potentially accel-
erate protective effects of tear mucous layer against exter-
nal antigens that cause local allergic reaction.
Phenotypes of a mutant mouse that lack each of MAMs
Muc1-null mouse
MUC 1 is reportedly involved in regulation of bacterial
pathogen-related local tissue inflammation (Table 3)
[42–45]. A Muc1-null mouse is fertile and grows overall
normally [46]. However, lacking Muc1 leads to obvious
phenotype in gastrointestinal tracts or airway epithelium
[45, 47]. Muc1-null mice showed the increase of bacter-
ial colonization of the stomach mucosa [43]. Muc1-
deficient tissue of gastrointestinal tract or intestinal
epithelial cell line with Muc1-silencing increase chemo-
kine expression in response to exposure to TNFα in
culture [43]. Muc1 play an important role in defense
mechanism against external bacterial contamination.
Muc1 knockout (KO) mice exhibited hyper- inflamma-
tory response in the airways during acute experimental
Pseudomonas aeruginosa- [44] or Haemophilis influen-
zae- lung infection [42] or in gastric mucosa upon
Helicobacter infection [43]. Moreover Lacking Muc1
also impairs cholesterol uptake and absorption in the di-
gestive tract [48]. In mice the loss of Muc1 significantly
suppressed intestinal cholesterol absorption as compared
with the wild-type mice, and the intestinal uptake rate of
cholesterol is significantly decreased compared with the
wild-type mice [48]. Muc1 is also involved in protective
system against bacterial infection in airway epithelium
[42, 44]. This mutant mouse does not exhibit a specific
phenotype; theocular surfaceofMuc1nullmiceofC57BL/
6 background appeared normal in all respects tested,
namely, the structure of the ocular surface epithelia, as
evaluated by using slit lamp biomicroscopy with fluores-
cein solution, bacterial adherence efficacy, and Muc4
mRNAexpression inocularsurface [49].Anotherpaperre-
ports that the incidence of conjunctivitis and blepharitis
was higher in aMun1-null mouse as compared with a wild
typemouse[50].
Muc2-null mouse
MUC2 is reportedly expressed in ocular surface [51, 52].
Although currently ocular phenotype of a Muc2-deficent
mouse has not yet been well investigated, phenotype in
other mucous organs, i.e., intestine, has well defined
[8, 53] and serves as a reference in examination of
ocular phenotype.
Expression of MUC2 is lowered in the patients with
inflammatory bowel disease. MUC2 plays a significant
role in the development of tissue inflammation, e. g., ex-
perimental colitis [8, 54, 55]. Muc2-deficient mice spon-
taneously developed colitis with diarrhea (Table 3),
rectal prolapse, and failure to thrive presumably by com-
mensal bacteria in tissue. Histological analysis of the
colon of Muc2-null mice shows mucosal epithelial thick-
ening, increased proliferation, and superficial mucous
epithelial defect. The histologic damage in the colitis-
inducing agent, dextran sulfate sodium (DSS)-treated
Muc2-deficient mice are different compared with wild
type and Muc2-heterozygous deficient mice, with many
crypt abscesses [8]. In the absence of Muc2, the com-
mensal bacteria are in direct contact with the epithelial
cells and the bacteria invade into the tissue cells, causing
infiltration of neutrophils and lymphocytes. Interestingly,
aberrant intestinal crypt morphology and altered cell
maturation and migration were recognized in Muc2-null
mice [53]. Moreover, the mice develop colorectal cancer
after several months (Table 3), further suggesting that
the phenotype resembles the patients with ulcerative
colitis [53].
Muc5Ac-deficient mouse lines
Wang et al. generated a transgenic mouse line with tar-
geted deletion of goblet cells [56]. Goblet cells were de-
leted with expression of diphtheria toxin A driven by a
Table 3 Characteristics of Muc knockout mice
Muc1 KO mice Bacterial pathogen-related local tissue inflammation
(gastrointestinal tract, airway)
Muc2 KO mice Spontaneous colitis, colorectal canser
Muc5AC KO mice Intestinal nematode infection
Muc13 KO mice More severe dextran sodium sulfate (DSS)-induced
colitis
Muc16 KO mice Inflammmation (conjunctiva)
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human MUC5AC promoter. In this mouse model the ex-
ternal appearance of the ocular surface and corneal path-
ology was normal [56]. Muc4 expression compensated the
decrease of Muc5AC by the loss of goblet cells as revealed
by immunohistochemical staining, in situ hybridization,
electronic microscopy, and RT-PCR [56]. Muc5AC pro-
tein is a critical component in the defense against intes-
tinal nematode infection as revealed by using a Muc5AC
deficient mouse model (Table 3) [57]. A related mouse
line, a Muc5B-null mouse, also does not show ocular
phenotype [58]. In another Muc5AC-null mouse line, cor-
neal opacity was reportedly observed in 11 % of the ani-
mals, but others appeared to be normal [59]. In this
mouse line there was a significant decrease of tear film
break up time and increase fluorescein staining (epithelial
disorder) on the ocular surfaces compared to WT mice
[59]. Tear volume was determined with the phenol red
thread tear test. Because total tear volume was not af-
fected by the loss of Muc5AC, loss of Muc5AC might im-
pair the quality of the tear fluid [59]. Further investigation
is to be performed to uncover the roles of Muc5AC in
ocular phenotype.
Muc13-null mouse
MUC13 is reportedly expressed in ocular surface [51, 52]
and digestive organs [47, 60]. Muc13, a member of MAM,
reportedly exhibits anti-inflammatory activity in mouse in-
testine [47, 60]. Lacking Muc13 causes spontaneous focal
inflammation presumably by the action of commensal bac-
teria as well as potentiates dextran sodium sulfate-induced
colitis in mice [60]. Muc13-null mice developed normally
with no spontaneous intestinal pathology except mild focal
neutrophilic inflammation in the small and large intestines
of old mice [60]. However, they developed more severe
acute colitis, as revealed by the loss of weight, rectal bleed-
ing, diarrhea and histological colitis scores compared with
wild-type mice when challenged with the colitis-inducing
agent, dextran sodium sulfate (DSS) (Table 3) [60]. These
findings promote us to hypothesize that gene ablation of
Muc13 might induce an ocular phenotype. Similar to the
situation in Muc2, ocular phenotype of a Muc13-deficent
mouse is also to be investigated.
Muc16-null mouse
Muc16 provides a protective barrier for the epithelial
surface from bacterial adhesion and to suppress the im-
mune system [25, 61–63]. Binding of fluorescently la-
beled Staphylococcus aureus to immortalized human
corneal-limbal epithelial (HCLE) cells was measured to
determine the role of MUC16 in the protection of
pathogen adherence on the ocular surface epithelium
[25]. An in vitro study sowed that knockdown of Muc16
Fig. 2 a Histology by Periodic acid-Schiff (PAS) staining of the conjunctival epithelium in WT mouse. In the conjunctiva, epithelial cells and
subepithelial fibroblasts are seen. PAS positive goblet cells were distributed in the conjunctival epithelium (arrows). Bar, 50 µm. b Expression pattern
of phsopho-Stat3 in ocular surface. Immunoreactivity for phospho-Stat3 was not observed in the corneal epithelium and keratocytes of both WT and
KO mice as well as in the WT conjunctiva(A, B). However, phospho-Stat3 immunoreactivity was detected in fibroblasts (arrows) in the subepithelial
connective tissue of KO mice (D, higher magnification in D’), but was not seen in the WT tissue (C, higher magnification in C’) Bar, 10 µm. Reproduced
from Shirai et al. [9]
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gene expression in cultured human ocular surface epi-
thelial cells promotes adhesion of Staphylococcus aureus
on cell surface [25]. In vivo role in ocular surface epithe-
lium was examined in Muc16-deficient mice, although
Muc16 is expressed in conjunctival, but not in corneal
epithelium, in mice, different from human [9]. Muc16-
deficient homozygous mutant mice are fertile and appear
normal without growth retardation [64]. Although the
histology showed no obvious abnormalities in conjunctiva,
subconjunctival fibroblasts express phospho-Stat3 with
the absence of Muc16 (Fig. 2b) [9]. As described above,
MAM members demonstrate anti-inflammatory activity.
The loss of Muc16 exhibits inflammatory consequence in
the conjunctiva (Table 3); it activates Stas3 signaling and
upregulates expression of IL-6 (Fig. 1 and 3) [9]. IL-6 up-
regulation secondarily affects proliferation and migration
of corneal epithelium [65, 66], as well as unfavorable fibro-
genic process by keratocytes (by myofibroblast transform-
ation) presumably via tear (Fig. 4) [9]. This is to be
strongly noted that lacking this conjunctiva-specific mucin
impairs the homeostasis of not only conjunctival but also
corneal epithelium. The finding shows an important im-
plication that dry eye-related conjunctival inflammation
secondarily impairs homeostasis of the cornea.
Conclusive remarks
In the future direction of research regarding mucins, ana-
lysis of ocular surface of mucin-gene related mutant
mouse lines are to be further performed. Because drugs
that stimulate mucin expression are clinically available. It
is possible that we can suppose the decrease of the specific
mucins in ocular surface disorder by the knowledge of the
characteristics of the specific mucin deficient mice. More-
over, if the drugs that promote the expression of each
mucin are developed, the increase of target mucin will
lead to the treatment of ocular surface disease.
Fig. 4 Immunolocalization of macrophages and analysis of keratocyte phenotype in healed cornea at 30 hours post-debridement.
Immunohistochemistry detects F4/80-labeled macrophages, aldehyde dehydrogenase 3A1 (ALDH3A1, keratocyte marker), and -smooth muscle actin
(SMA, myofibroblast marker). F4/80-labeled macrophages were more frequently observed beneath the regenerated epithelium in the KO mouse
(b), while few F4/80-labeled cells were seen in the WT corneas (a). The cells in the posterior stroma were labeled for ALDH3A1, while fibroblastic cells
in the anterior stroma were not labeled in the WT cornea (c). In the KO cornea, the majority of the cells in the stroma were negative for ALDH3A1
(d). A few -smooth muscle actin-positive myofibroblasts were detected in the WT stroma (e). Almost all the stromal cells were labeled with anti-SMA
antibody and thus were myofibroblasts in the KO cornea (f). Bar, 50 μm. Reproduced from Shirai et al. [9]
Fig. 3 Expression of IL-6 in cornea and conjunctiva. The loss of
Muc16 promotes the mRNA expression of IL-6 in the conjunctiva
(*p < 0.05), but not affected the mRNA expression of IL-6 in the
cornea. Reproduced from Shirai et al. [9]
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